JIVCX
Price
$30.43
Change
+$0.17 (+0.56%)
Updated
Jul 3 closing price
Net Assets
150.71M
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

JIVCX vs VIVAX

Header iconJIVCX vs VIVAX Comparison
Open Charts JIVCX vs VIVAXBanner chart's image
JPMorgan U.S. Applied Data Sci Val C
Price$30.43
Change+$0.17 (+0.56%)
VolumeN/A
Net Assets150.71M
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
JIVCX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JIVCX vs. VIVAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JIVCX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. JIVCX (151M). VIVAX pays higher dividends than JIVCX: VIVAX (2.06) vs JIVCX (1.10). JIVCX was incepted earlier than VIVAX: JIVCX (20 years) vs VIVAX (33 years). JIVCX (1.56) is less costly to investors than VIVAX (0.17). JIVCX is a more actively managed with annual turnover of: 22.00 vs. VIVAX (9.00). JIVCX has a lower initial minimum investment than VIVAX: JIVCX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. JIVCX (6.84). VIVAX return over 5 years is better than : 80.14 vs. JIVCX (27.08).
JIVCXVIVAXJIVCX / VIVAX
Total Expense Ratio1.230.17724%
Annual Report Gross Expense Ratio1.560.17918%
Fund Existence20 years33 years-
Gain YTD6.5116.209105%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets151M189B0%
Annual Yield % from dividends1.102.0654%
Returns for 1 year6.8412.0457%
Returns for 3 years19.5835.1656%
Returns for 5 years27.0880.1434%
Returns for 10 years-4.21115.74-4%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOL1.910.03
+1.60%
Emeren Group Ltd
CE60.880.26
+0.43%
Celanese Corp
BNL16.340.03
+0.18%
Broadstone Net Lease
BCLI1.16-0.01
-0.85%
Brainstorm Cell Therapeutics
ECX2.16-0.04
-1.82%
ECARX Holdings